Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (8,327,897)	$ (10,603,477)	$ (11,534,895)	$ (9,659,918)	$ (18,931,374)	$ (21,194,813)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense					3,425,733	4,185,857
Issuance of shares in consulting agreement					267,000	610,000
Amortization of debt discount	283,774		121,997		554,010	233,523
Depreciation expense					10,194	7,891
Operating lease expense					0	120,514
Finance lease depreciation expense					19,339	20,627
Changes in assets and liabilities:
Prepaid expenses and other assets					66,806	(65,728)
Accounts payable					(3,730,334)	3,195,618
Accrued expenses					(477,471)	(4,937,383)
Operating lease liabilities					0	(179,136)
Net cash used in operating activities					(18,796,097)	(18,003,030)
Cash flows from investing activities:
Purchase of equipment					(28,999)	0
Net cash used in investing activities					(28,999)	0
Cash flows from financing activities:
Proceeds from exercise of stock options					531,091	8,849
Payments of finance lease obligations					(27,261)	(33,253)
Proceeds from issuance of common stock, net of issuance costs	0				19,494,473	4,832,265	$ 16,100,000
Net cash provided by financing activities					19,998,303	4,807,861
Net increase in cash and cash equivalents					1,173,207	(13,195,169)
Cash and cash equivalents at beginning of period		$ 56,560,517		$ 73,820,160	56,560,517	73,820,160	73,820,160
Cash and cash equivalents at the end of period	$ 57,733,724		$ 60,624,991		57,733,724	60,624,991	$ 56,560,517
Supplemental information of cash and non-cash transactions:
Cash paid for interest					$ 2,362,716	$ 1,962,241